Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis"

被引：0
|
作者：
Giuliani, Jacopo [1 ]
Martelli, Salvatore [2 ]
Piacentini, Paolo [1 ]
Bonetti, Andrea [1 ]
机构：
[1] ASL 21 Reg Veneto, Dept Oncol, Mater Salutis Hosp, I-37045 Legnago Verona, Italy
[2] ASL 21 Reg Veneto, Dept Radiol, Mater Salutis Hosp, I-37045 Legnago Verona, Italy
来源：
TUMORI | 2015年 / 101卷 / 01期
关键词：
PLUS BEVACIZUMAB; POOLED ANALYSIS; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; THERAPY; EVENTS;
D O I：
10.5301/tj.5000258
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [21] Mean Platelet Volume as a Prognostic Marker in Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Combined Chemotherapy
    Tuncel, Tolga
    Ozgun, Alpaslan
    Emirzeoglu, Levent
    Celik, Serkan
    Bilgi, Oguz
    Karagoz, Bulent
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (15) : 6421 - 6423
  • [22] Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study
    Alt, Marie
    Truant, Stephanie
    Renaud-Vantroys, Thibaut
    Sequier, Cedric
    Duhamel, Alain
    El Amrany, Mehdi
    Turpin, Anthony
    Makhloufi, Samira
    Pruvot, Francois Rene
    Hebbar, Mohamed
    ANTICANCER RESEARCH, 2016, 36 (10) : 5551 - 5555
  • [23] Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)
    Jin, Ran
    Ogbomo, Adesuwa S.
    Accortt, Neil A.
    Lal, Lincy S.
    Bishi, Geetanjali
    Sandschafer, Darcie
    Goldschmidt, Jerome H.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [24] Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer A Randomized Clinical Trial
    Venook, Alan P.
    Niedzwiecki, Donna
    Lenz, Heinz-Josef
    Innocenti, Federico
    Fruth, Briant
    Meyerhardt, Jeffrey A.
    Schrag, Deborah
    Greene, Claire
    O'Neil, Bert H.
    Atkins, James Norman
    Berry, Scott
    Polite, Blase N.
    O'Reilly, Eileen M.
    Goldberg, Richard M.
    Hochster, Howard S.
    Schilsky, Richard L.
    Bertagnolli, Monica M.
    El-Khoueiry, Anthony B.
    Watson, Peter
    Benson, Al B., III
    Mulkerin, Daniel L.
    Mayer, Robert J.
    Blanke, Charles
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2392 - 2401
  • [25] Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease
    Bruera, Gemma
    Cannita, Katia
    Di Giacomo, Daniela
    Lamy, Aude
    Troncone, Giancarlo
    Dal Mas, Antonella
    Coletti, Gino
    Frebourg, Thierry
    Sabourin, Jean Christophe
    Tosi, Mario
    Ficorella, Corrado
    Ricevuto, Enrico
    BMC MEDICINE, 2012, 10
  • [26] Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial
    Kurreck, Annika
    Heinemann, Volker
    von Weikersthal, Ludwig Fischer
    Decker, Thomas
    Kaiser, Florian
    Uhlig, Jens
    Schenk, Michael
    Freiberg-Richter, Jens
    Peuser, Bettina
    Denzlinger, Claudio
    Graeven, Ullrich
    Heinrich, Kathrin
    Held, Swantje
    Stahler, Arndt
    Alig, Annabel Helga Sophie
    Jelas, Ivan
    von Einem, Jobst C.
    Stintzing, Sebastian
    Giessen-Jung, Clemens
    Modest, Dominik P.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    Oesterlund, P.
    Soveri, L. -M
    Isoniemi, H.
    Poussa, T.
    Alanko, T.
    Bono, P.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 599 - 604
  • [28] Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces
    Beca, J. M.
    Dai, W. F.
    Pataky, R. E.
    Tran, D.
    Dvorani, E.
    Isaranuwatchai, W.
    Peacock, S.
    Alvi, R.
    Cheung, W. Y.
    Earle, C. C.
    Gavura, S.
    Chan, K. K. W.
    CLINICAL ONCOLOGY, 2022, 34 (01) : E7 - E17
  • [29] Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab
    Smith, Christopher G.
    Fisher, David
    Claes, Bart
    Maughan, Timothy S.
    Idziaszczyk, Shelley
    Peuteman, Gilian
    Harris, Rebecca
    James, Michelle D.
    Meade, Angela
    Jasani, Bharat
    Adams, Richard A.
    Kenny, Sarah
    Kaplan, Richard
    Lambrechts, Diether
    Cheadle, Jeremy P.
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4104 - 4113
  • [30] The prognostic and predictive significance of plasma type 1 plasminogen activator inhibitor and endoglin in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    Bal, Oznur
    Ekinci, Ahmet Siyar
    Dogan, Mutlu
    Atay, Cigdem
    Demirci, Ayse
    Oksuzoglu, Berna
    Kilic, Selim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (01) : 48 - 53
12345